Related Experiment Videos
[Uveal melanomas in patients less than 20 years of age]
C Gailloud1, L Zografos, L Bercher
1Hôpital Ophtalmique Universitaire Jules Gonin, Lausanne.
Abstract:
During the past 15 years we observed 21 uveal tumors in patients aged 20 years and younger. Four of them were younger than 10 years, 4 were 11 to 15 years' old, 4 ranged from 16-17 years and 9 from 18-20 years. An accelerated beam irradiation was applied in 11 cases, a surgical excision was carried out in 4 cases, and a 60 CO-applicator used for 3 patients. Three enucleations were carried out straight away. In this study we present the clinical characteristics of melanomas of young people, the therapy used, as well as the systematic analysis of the vital prognosis of the patients and of the functional prognosis of the eyes under treatment.
Insights
This study analyzed 21 uveal tumors in young patients, detailing their clinical features, treatments like irradiation and surgery, and outcomes. It provides insights into the prognosis for pediatric and adolescent melanoma patients.
Area of Science:
- Ophthalmology
- Oncology
- Pediatric Medicine
Context:
- Uveal tumors are rare in pediatric and adolescent populations, making their study crucial for understanding disease patterns in younger individuals.
- This research focuses on a cohort of 21 patients aged 20 years and younger diagnosed with uveal tumors over 15 years.
Purpose:
- To characterize the clinical presentation of uveal tumors in young patients.
- To evaluate the therapeutic strategies employed, including accelerated beam irradiation, surgical excision, and brachytherapy (60CO-applicator).
- To systematically analyze the vital and functional prognosis for these young patients and their eyes.
Summary:
- The study observed 21 uveal tumors in patients aged 20 and under, with varying age distributions.
- Treatment modalities included accelerated beam irradiation (11 cases), surgical excision (4 cases), 60CO-applicator (3 cases), and immediate enucleation (3 cases).
- Clinical characteristics, treatment outcomes, and prognostic factors for survival and ocular function were analyzed.
Impact:
- Provides essential data on the management and outcomes of rare pediatric and adolescent uveal tumors.
- Informs clinical decision-making for oncologists and ophthalmologists treating young patients with ocular malignancies.
- Contributes to the understanding of long-term survival and vision preservation in this specific demographic.